Tech Company Financing Transactions
Systems Oncology Funding Round
On 10/23/2019, Systems Oncology raised funding from Pritzker Group Venture Capital.
Transaction Overview
Company Name
Announced On
10/23/2019
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Pritzker Group Venture Capital (Joseph Gleberman)
Proceeds Purpose
The funding will be used to invest in both discovery research and pre-clinical development to evolve SO's rapidly expanding pipeline of innovative cancer therapeutics.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
7201 E. Henkel Way 205
Scottsdale, AZ 85255
USA
Scottsdale, AZ 85255
USA
Phone
Website
Email Address
Overview
Systems Oncology (SO) combines multi-scalar systems modeling with machine learning and big data to uncover breakthrough insights into cancer biology and expose new therapeutic vulnerabilities. These discoveries are then used to better develop truly novel therapeutic agents.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Spyro Mousses
Chief Financial Officer
Andrew Matricaria
Chief Technical Officer
Chris Yoo
Vice President
Chris Brown
VP - Bus. Development
Gavin Bogle
VP - Bus. Development
Lee Matricaria
VP - Marketing
Teresa Niu
VP - Operations
Katy Marhenke
VP - R & D
Jeffrey Kiefer
Browse more venture capital transactions:
Prev: 10/23/2019: Aurora Insight venture capital transaction
Next: 10/23/2019: PeerNova venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on funding rounds that are announced publicly. VC investment data records reported here come from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs